Opthea Limited (OPT) Financials

OPT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 113.4 million 145.4 million
2023-06-30 65.4 million 69.3 million
2023-03-31 99.0 million 104.9 million
2022-12-31 104.9 million 66.4 million

OPT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -47.6 million ?
2023-06-30 -33.5 million 3.0 million
2023-03-31 -25.8 million 1.5 million
2022-12-31 -47.1 million 2.9 million

OPT Net Income

No data available :(

OPT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 107.0 million - -
2023-06-30 59.2 million - 120552
2023-03-31 89.5 million - -
2022-12-31 96.6 million - 143492

OPT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 50.5 million
2023-06-30 41.1 million
2023-03-31 280.7 million
2022-12-31 42.2 million

OPT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2922 58.1 million - -
2023-06-30 9802 40.0 million 13.1 million 6.1 million
2023-03-31 7495 30.5 million 6.6 million 1.4 million
2022-12-31 4774 41.8 million 14.6 million 2.7 million

OPT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 41745 35116
2023-06-30 37065 84869
2023-03-31 94467 42766
2022-12-31 35447 81668

OPT

Price: $3.28

52 week price:
1.60
4.42

Earnings Per Share: -2.41 USD

P/E Ratio: -1.22

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 800

Market Capitalization: 314.8 million

Links: